North America Blood Cancer Diagnostics Market Size & Outlook
North America blood cancer diagnostics market, 2018-2030 (US$M)
Related Markets
North America blood cancer diagnostics market highlights
- The North America blood cancer diagnostics market generated a revenue of USD 4,800.2 million in 2023.
- The market is expected to grow at a CAGR of 6.9% from 2024 to 2030.
- In terms of segment, outpatient facilities was the largest revenue generating end use in 2023.
- Research & Manufacturing is the most lucrative end use segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 4,800.2 million |
| Market revenue in 2030 | USD 7,660.8 million |
| Growth rate | 6.9% (CAGR from 2023 to 2030) |
| Largest segment | Outpatient facilities |
| Fastest growing segment | Research & Manufacturing |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hospitals, Outpatient Facilities, Research & Manufacturing |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Roche Holding AG, Qiagen NV, Becton Dickinson & Co, Siemens Healthineers AG ADR, Thermo Fisher Scientific Inc, Hologic Inc, Koninklijke Philips NV, Illumina Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 46.2% of the global blood cancer diagnostics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,771.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood Cancer Diagnostics Market Scope
Blood Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America blood cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 66.07% in 2023. Horizon Databook has segmented the North America blood cancer diagnostics market based on hospitals, outpatient facilities, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
In North America, the blood cancer diagnostics market is driven by several factors, such as increasing prevalence of blood cancer, increasing R&D studies and trials, and technological advancements in diagnostic methods. Various diagnostic tools & techniques are available in the market, including liquid biopsy, Positron Emission Tomography (PET), Next-Generation Sequencing (NGS) testing solutions, and molecular testing.
For instance, Agilent Technologies licensed the blood cancer assay, PanHeme, developed by Roswell Park Cancer Center in North America. The market is further driven by ongoing government and institutional programs & initiatives in the region.
For instance, in October 2023, an innovative program to slow the growth of Relapsed/Refractory Multiple Myeloma (RRMM) was launched by Florida Cancer Specialists & Research Institute, LLC (FCS). The cutting-edge treatment, teclistamab (TECVAYLI), utilizes the body's immune system to combat cancer.
Reasons to subscribe to North America blood cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America blood cancer diagnostics market databook
-
Our clientele includes a mix of blood cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America blood cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into North America blood cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America blood cancer diagnostics market size, by country, 2018-2030 (US$M)
North America Blood Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
